\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Nov 20, 2009 8:30 AM EST \n\n \n Dendreon Receives FDA Acknowledgement of Complete Response - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Nov 12, 2009 6:45 AM EST \n\n \n Unbiased Analysis on FITB, HCBK, ADSK, HBAN, FINL and DNDN Posted on WallStSense.com - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 11, 2009 4:00 PM EST \n\n \n Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Nov 03, 2009 6:14 AM EST \n\n \n BenchmarkJournal.com Issues Independent Review on FINL, FSLR, EWBC, FITB, BARE and DNDN - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 02, 2009 8:31 AM EST \n\n \n Dendreon Completes Submission of Biologics License Application for PROVENGE - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Oct 30, 2009 7:30 AM EDT \n\n \n Dendreon to Hold Conference Call on Wednesday, November 11, 2009 at 4:30 PM ET - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Oct 29, 2009 7:30 AM EDT \n\n \n Dendreon Announces Webcast Presentations at Upcoming Investor Conferences - PR Newswire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");